EQT Solidifies Position In Life Sciences With LSP Acquisition

Sweden-based private markets firm EQT AB agreed to purchase life sciences venture capital fund Life Sciences Partners (LSP). LSP's purchase will further strengthen EQT's position in healthcare investments.

The deal presents a lot of advantages for EQT as well as LSP. Given EQT's scale as a PE firm and LSP's broad life sciences network, the deal will allow them to scale up their life sciences investments. The acquisition will further increase the potential scope of sales for both parties. Moreover, the value will also provide access to new investment opportunities and a broadened investable universe for both parties.

Furthermore, given LSP's highly experienced team, the deal will complement EQT's existing knowledge base within life sciences. It will also expand EQT's ability to suppo...

Login In


Register now for free access

Notify of
Inline Feedbacks
View all comments